Virtual City Wide Medical Grand Rounds: The Expanding Multiverse of Sodium-Glucose Linked Transporter Inhibition (SGLTi) In and Beyond Diabetes

The Expanding Multiverse of Sodium-Glucose Linked Transporter Inhibition (SGLTi) In and Beyond Diabetes

Bruce A. Perkins MD, MPH

Professor, Division of Endocrinology 
Director, Leadership Sinai Centre for Diabetes, Sinai Health

Susanna Mak MD, PhD

Associate Professor, Department Division Director, Cardiology
Director, Anna Prosserman Heart Function Clinic, Sinai Health

Learning objectives:

At the end of the presentation, participants should be able to:

1. Explain the mechanisms of glucose-lowering, and kidney and heart protection from SGLTi,
2. Describe the rapidly-evolving impact of SGLTi clinical trials on diabetes, renal, and cardiovascular practice, and
3. Identify key findings from SGLTi trials meant to overcome limitations in type 1 diabetes care.

Accreditation:

City Wide Medical Grand Rounds is a self-approved group learning activity (Section 1) as defined by the Maintenance of Certification program of the Royal College of Physicians and Surgeons of Canada.

Printable poster:

CWMGR Poster - 22-09-21